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Abstract
This review article focuses on the differential activation of the hypothalamic-pituitary-adrenal (HPA) axis in generalized anxiety 
and panic. The results of experimental studies that assayed adrenocorticotropic hormone, cortisol and prolactin show that real-life 
panic attacks as well as those induced by selective panicogenic agents, such as lactate and carbon dioxide, do not activate the HPA 
axis. Accordingly, experiments carried out in two animal models of panic, namely electrical stimulation of the dorsal periaqueductal 
gray matter of the rat and the escape from the open arm of the elevated T maze, have shown that in neither case stress hormones 
are increased in the plasma. Also in humans, reported results have shown that neither cortisol nor prolactin levels were increased 
following simulated public speaking, an experimental task that has been related to panic, in either healthy volunteers or patients 
with panic disorder diagnosis. Therefore, although the panic attack causes a major sympathetic stimulation, it has little effect on 
the HPA axis. In contrast, anticipatory or generalized anxiety activates both the HPA and the sympatho-adrenal axes. Keywords: 
stress hormones, generalized anxiety, panic, simulated public speaking, periaqueductal gray matter, elevated T maze.
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Introduction
The concept of stress is based on the observation that 
different kinds of physical or psychological demands 
on the organism elicit the same set of bodily changes, 
the so called General Adaptation Syndrome (GAS) 
(Selye, 1936; Ursin & Olff, 1993). However, Hans 
Selye (1974) himself acknowledged that the original 
name was not the best one: “…when I introduced the 
word stress …, my English was not yet good enough for 
me to distinguish between the words stress and strain. 
It was not until several years later that the British 
Medical Journal called my attention … that according 
to Selye stress is its own cause. Actually I should have 
called my phenomenon the strain reaction and that 
which causes it ‘stress’, which would parallel the use 
of these terms in physics. However, … biological stress 
in my sense of the word was so generally accepted 
in various languages that I could not have redefined 
it. Hence, I was forced to create a neologism and 
introduce the word stressor, for the causative agent, 
… retaining stress for the resulting condition”. (Selye, 
1974, as cited in Pacák & Palkovits, 2001). 
 The most characteristic stress response is the 
release of the adrenocorticotropic hormone (ACTH) 
and corticoids (cortisol in humans and cortisone in the 
rat) into the blood stream as a result of activation of the 
hypothalamic-pituitary-adrenal (HPA) axis. In addition to 
the HPA axis, acute stress also activates the sympathetic 
division of the neurovegetative nervous system as part of 
the fight/flight reaction, or emergency response, defined 
by Walter Cannon (1914). As a result, noradrenaline is 
released from peripheral sympathetic nerve fibers in 
different tissues, and adrenaline (also some noradrenaline), 
from the adrenal medulla into the blood stream.
More recently, McEwen has introduced the 
concept of allostasis, that is, maintaining stability 
through behavioral change, as a fundamental process 
through which animals actively adjust to predictable 
or unpredictable stressors; allostatic load refers to the 
cumulative cost of allostasis to the organism, with 
allostatic overload being a state in which pathology can 
occur (McEwen & Wingfield, 2003). 
Stressors may be physical, such as tissue damage 
or extreme changes in temperature, but may also be 
psychological. As to the latter, reported results have 
consistently shown that the HPA axis and sympathetic 
nervous system are activated by novelty or cues that 
signal the delivery of punishment or the withholding 
of an expected reward (frustration), thus generating 
anticipatory anxiety. The neural circuits that mediate 
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the neuroendocrine responses to psychological stressors 
include the cortical activation of the basolateral nucleus 
of the amygdala, which in turn activates its central 
nucleus. The message is then conveyed to hypothalamic 
neurons by different pathways: a direct one, an indirect 
one, through the bed nucleus of the stria terminalis, and 
still another one, through brainstem serotonin (5-HT) 
and catecholamine-containing neurons. Neurons of 
the hypothalamic paraventricular nucleus secrete 
the corticotropic releasing hormone (CRH) into the 
portal circulation of the pituitary gland. In the anterior 
pituitary, CRH stimulates ACTH-secreting cells that 
release ACTH into the blood stream. ACTH acts on the 
adrenal cortex promoting cortisol release into the blood 
stream. In addition to ACTH, prolactin is consistently 
released at the anterior pituitary in stressful conditions 
(Van der Kar & Blair, 1999).
To test the GAS hypothesis, Miklós Palkovits 
and coworkers have used five different stressors: 
immobilization, hemorrhage, cold exposure, pain, or 
hypoglycemia. With the exception of immobilization 
stress, these stressors also differed in their intensities. 
Their results showed marked heterogeneity of 
neuroendocrine responses to various stressors and that 
each stressor has a neurochemical “signature.” By 
examining changes of Fos immunoreactivity in various 
brain regions upon exposure to different stressors, 
they also described stressor-specific pathways and 
circuits. As a result, they have defined stress as a state 
of threatened homeostasis (physical or perceived threat 
to homeostasis) that triggers stimulus-specific adaptive 
compensatory responses. The adaptive response 
reflects the activation of specific central circuits and 
is genetically and constitutionally programmed and 
constantly modulated by environmental factors (Pacák 
& Palkovits, 2001). This view may help to understand 
the seeming paradox on panic attacks and the HPA axis 
that is discussed in the following section.
Defense-related emotions
Anxiety, fear and panic are emotions related to 
threat. The distinction between anxiety and fear has not 
always been clear, but the ethoexperimental approach 
developed by Robert and Caroline Blanchard (Blanchard 
& Blanchard, 1988) has provided a sound criterion based 
on the systematic study of animal defensive strategies 
against predators. From this perspective, anxiety is 
the emotion related to risk-assessment behavior that 
is evoked in situations when the danger is uncertain 
(potential threat); either because the context is novel or 
because the danger stimulus (e.g., a predator) had been 
present in the past, but is no longer in the environment. 
The notion of risk assessment overlaps with that of 
conflict, which is a cornerstone of anxiety research. In 
contrast, fear is related to defensive strategies that occur 
in response to actual danger that is at a certain distance 
from the prey (distal threat). In this case, the animal 
either evades the situation, whenever an escape route 
is available or becomes tensely immobilized (freezing), 
when there is no way out. Finally, panic corresponds to 
the vigorous flight reaction evoked by very close danger 
(proximal threat), such as an approaching predator or by 
acute cutaneous pain. Complete immobility also occurs 
in response to proximal danger, as well as defensive fight, 
which occurs when flight is impossible. Nevertheless, 
the latter strategy relates to rage, rather than to panic 
(see also Gray & McNaughton, 2000, McNaughton & 
Corr, 2004). Concerning psychopathology, it has been 
suggested that the same neurobiological processes that 
regulate anticipatory anxiety are involved in generalized 
anxiety disorder (GAD); the ones that control fear, in 
phobic disorders, and those organizing proximal defense, 
in panic disorder (PD) (Deakin & Graeff, 1991).
According to the DSM IV classification of 
psychiatric disorders (American Psychiatric Association, 
1994), PD is characterized by the occurrence of panic 
attacks, in which feelings of extreme fear and dread 
strike unexpectedly and repeatedly, accompanied by 
intense physiological symptoms. Over time, anticipatory 
anxiety about having a further attack and avoidance of 
places where having an attack is embarrassing develop. 
The extreme form of avoidance is agoraphobia, in 
which case the person is afraid of leaving home alone. 
In contrast, the main symptom of GAD is exaggerated 
worry and tension over every day events and decisions, 
lasting for at least six months. In addition to the different 
clinical manifestations, the pharmacological profile of 
these disorders also differs: GAD is rapidly ameliorated 
by anxiolytic drugs, PD by chronic administration of 
antidepressants (Nutt, 2005).
Emotions, either normal or abnormal, are manifested 
in both psychological (cognitive, affective, behavioral) 
and physiological (neurovegetative, neuroendocrine) 
domains. The question that is central to the present 
article is whether anxiety/GAD and panic/PD differ 
qualitatively or only quantitatively as to the activation 
of the HPA axis.
Neuroendocrinology of panic and anxiety
A naturally occurring PA can be considered as a 
traumatic stressor (McNally & Lukach, 1992). Assuming 
the GAS hypothesis – there is single stereotyped hormonal 
response to all kinds of stressors –, it is expected that 
the HPA axis would be much more activated by a panic 
attack than by anxiety. Yet, the majority of the reported 
results indicate that the HPA axis is little affected by 
PAs. Thus, a review of the literature on stress hormone 
responses during PAs (Graeff, Garcia-Leal, Del-Ben, 
& Guimarães, 2005) showed that real-life PAs as well 
as those induced by selective panicogenic agents, such 
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as lactate and carbon dioxide, do not activate the HPA 
axis. Agonists of the colecystokinin receptor B, such as 
the colecystokinin-4 peptide (CCK-4) and pentagastrin, 
increase stress hormones regardless of the occurrence of 
a PA and thus seem to activate the HPA axis directly. The 
benzodiazepine antagonist flumazenil does not increase 
stress hormones, but this agent does not reliably induce 
a PA. Pharmacological agents that increase anxiety 
in both normal subjects and panic patients, such as 
yohimbine, 1-(m-chlorophenyl) piperazine (mCPP), 
fenfluramine and caffeine and mCPP consistently raised 
stress hormone levels.
The above evidence indicates that natural PAs fail 
to activate the HPA axis, in contrast to anticipatory 
anxiety. Yet, the HPA axis responsivity to mild stress 
seems to be normal in children of parents with PD 
(Battaglia et al., 1997), but in adult PD patients, there 
is a reduced response to mild stress (Stones, Groome, 
Perry, Hucklebridge, & Evans, 1999) as well as to 
a combined dexamethasone-corticotropin-releasing 
hormone challenge (Schreiber, Lauer, Krumrey, 
Holsboer, & Krieg, 1996). Therefore, the HPA axis 
may become progressively desensitized after repeated 
exposure to PAs (Van Duinen, Schruers, Maes, & Griez, 
2006). Another possibility is the uncoupling of the HPA 
axis and the noradrenergic-hypothalamic-pituitary-
adrenal axis, which is always markedly activated during 
the PA (Coplan et al., 1995). In contrast to PD, both the 
HPA axis and the sympatho-adrenal axis are activated 
by anticipatory anxiety (Mason, 1975). In acute anxiety, 
the activation of the HPA axis is adaptive, since among 
other things corticoids seem to reduce perceived fear 
by impairing memory retrieval of emotionally arousing 
information (Soravia et al., 2006).
Experimental tests of the hypothesis that brain 
systems involved in PA do not activate the HPA axis 
have been conducted in animal models of anxiety and in 
human experimental anxiety trials.
Tests with animal models of anxiety
Since the PAG has been implicated in the PA, 
electrical or chemical stimulation of this brain structure 
has been used as an animal model of panic (see Graeff & 
Zangrossi Jr., 2002). In one of these models, developed 
by L.C. Schenberg and coworkers, behavioral items 
evoked by electrical stimulation of the dorsal PAG of 
the rat, such as freezing, running, galloping, and so on 
were measured. The most important finding was that 
PAG-evoked galloping was selectively attenuated by 
clinically-effective panicolytics, given in a dose-regimen 
and time-course not far from those of panic therapy. 
Particularly, galloping was either attenuated or virtually 
abolished by 21-day administration of the 5-HT reuptake 
inhibitors clomipramine and fluoxetine. Treatments 
that are clinically ineffective on PD, such as the acute 
administration of these antidepressants and diazepam, or 
the acute and 10-day administration of buspirone, did not 
attenuate the PAG- evoked behaviors. In addition, PAG-
evoked galloping was selectively facilitated by peripheral 
injections of pentylenetetrazole, a putative panicogen in 
humans (Schenberg, Bittencourt, Sudre, & Vargas, 2001; 
Schenberg, Capucho, Vatanabe, & Vargas, 2002; Vargas & 
Schenberg, 2001). These pharmacological results indicate 
that galloping induced by DPAG electrical stimulation is 
a reliable panic model.
Using this model, Schenberg, Dos Reis, Ferreira 
Póvoa, Tufik and Silva (2008) have examined whether the 
plasma levels of stress hormones are changed following 
PAG-evoked behaviors. The obtained results have shown 
that ACTH and prolactin plasma concentrations remain 
unaltered following the PAG-evoked defensive reactions. 
Not even a 5 minute electrical stimulation of the dorsal 
PAG at the flight threshold intensity significantly 
changed ACTH plasma level. The activity of the HPA 
axis has also been assessed in another experimental 
model that associates flight/escape behavior with PA, the 
elevated T-maze (for a review of this model see Graeff 
& Zangrossi, 2002; Pinheiro, Zangrossi, Del-Ben, & 
Graeff, 2007). As this test also allows the measurement of 
inhibitory avoidance, it has been possible to draw direct 
comparisons on the activity of the axis after expression of 
a PA or a GAD-related defensive response. The elevated 
T-maze is derived from the elevated plus-maze by sealing 
the entrance to one of its enclosed arms. As a result, the 
T-maze consists of three arms of equal dimension (50 
x 12 cm) elevated 50 cm from the floor. One of these 
arms is enclosed by lateral walls (40 cm high) and stands 
perpendicular to the two opposite open arms. When 
placed at the end of the enclosed arm, the rat does not 
see the open arms until it pokes its head beyond the walls 
of the closed arm. Being on the open arm seems to be 
an aversive experience, since rats have an innate fear of 
height and openness (Treit, Menard, & Royan, 1993). 
This would allow the animal to learn inhibitory avoidance 
if repeatedly placed inside the enclosed arm to explore 
the maze. On the other hand, when the rat is placed at 
the end of one of the open arms it can move towards the 
closed arm, presumably performing an escape response. 
The pharmacological exploration of the T-maze showed 
that these two defensive tasks are differently affected by 
drug treatments. Thus, compounds representative of three 
classes of anxiolytics - namely the agonist of BZD receptors 
diazepam, the serotonin 5-HT1A agonist buspirone, and 
the nonselective 5-HT2 antagonist ritanserin - have been 
shown to selectively impair inhibitory avoidance while 
leaving escape unchanged. These results are compatible 
with the view that inhibitory avoidance relates to GAD. 
In contrast, the escape task is insensitive to different 
classes of anxiolytics, and is impaired by chronic, but not 
acute administration of imipramine, clomipramine and 
fluoxetine, drugs that are used to treat PD.  
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Figure 1 (upper panel) shows the latency to leave the 
arms of the elevated T-maze on 3 consecutives trials. It can 
be seen that the latency to leave the enclosed arm increases 
across trials, indicating the acquisition of inhibitory 
avoidance. Latency to leave one of the T-maze open 
arms (escape) or one of the arms of a maze consisting of 
three enclosed arms (control) did not significantly change 
across trials. As shown in the lower panel of Figure 1, 
plasma levels of corticosterone are significantly higher 
in animals that acquired inhibitory avoidance, once again 
indicating the differential activation of the HPA axis on 
GAD and PA-associated behaviors.  
Tests with human experimental anxiety
The main psychological procedures for 
inducing experimental anxiety in human beings 
for pharmacological studies have been the aversive 
conditioning of the skin conductance response and the 
simulated public speaking (SPS) tests. While the drug 
profile of the former is similar to that of GAD, SPS has 
a pharmacological profile that resembles PD and social 
anxiety disorder, and is believed to mobilize the same 
neural network that is involved in these disorders (for 
a review, see Graeff, Parente, Del-Ben, & Guimarães, 
2003). As a consequence, two studies have been 
conducted by our research group to investigate whether 
SPS would affect HPA axis functioning.
In the SPS test, each participant is requested to 
prepare a speech and talk in front of a videocamera, the 
performance being recorded on videotape. Anxiety and 
other subjective states are evaluated by a psychometric 
instrument, the Visual Analog Mood Scale (VAMS). 
Also, bodily symptoms related to anxiety are assessed 
by the Bodily Symptom Scale (BSS). In the first 
endocrinological study (Garcia-Leal et al., 2005), 
the participants were divided into three groups: 18 
symptomatic panic patients, 16 nonsymptomatic, drug-
treated panic patients, and 17 healthy controls. Along 
the experimental session, the VAMS anxiety index and 
the total score of the BSS were higher in symptomatic 
patients than in controls, nonsymptomatic patients lying 
in between. In every group, the level of salivary cortisol 
was high at the beginning of the experimental session, 
and decreased after 70 minutes. This fall parallels 
the decrease in the VAMS anxiety factor and in BSS 
ratings, and appears to reflect habituation of the initial, 
anticipatory anxiety evoked by exposure to the new 
and potentially threatening laboratory environment. 
Accordingly, there has been a positive correlation 
between the initial level of cortisol and VAMS anxiety 
scores for the three groups, taken together. Preparation 
and performance of speech raised the VAMS anxiety 
index and BSS scores to the initial levels, but failed to 
increase salivary cortisol measured along 60 minutes, 
starting at the end of the speech (Figure 2). Therefore, 
SPS does not seem to activate the HPA axis, in contrast 
to anticipatory anxiety.
The second study was aimed at evaluating the 
effects of escitalopram, a very potent and selective 5-HT 
reuptake inhibitor, on SPS (Garcia-Leal, Del-Ben, Leal, 
Graeff, & Guimarães, 2009). Healthy male volunteers 
received, in a double-blind randomized design, placebo 
(n = 12), 10 (n = 17) or 20 (n = 14) mg of escitalopram, 
two hours before the test. Both doses of escitalopram 
did not affect the increase in VAMS anxiety scores 
determined by speech preparation or performance, but 
prolonged the rise induced by SPS. The most important 
results for the present argument are that the test itself did 
not significantly change cortisol plasma levels; neither 
did it change the levels of prolactin. Therefore, once 
more SPS failed to activate the HPA axis. However, 
under the highest dose of escitalopram, cortisol and 
prolactin increased immediately after the SPS (Figure 
3). The last result suggests that 5-HT modulates the 
release of stress hormones.
Figure 1. Upper panel: Bar chart comparing latencies (mean 
+ SEM) taken by rats to withdraw from an enclosed arm of an 
enclosed T-maze (control) or from the enclosed (avoidance) 
or open (escape) arm of the elevated T-maze, in three 
consecutive trials (L1, L2 and L3).*P < .05 (Duncan’s test) 
compared with all other groups. Lower panel: Mean + SEM of 
plasma corticosterone levels measured immediately after the 
performance of control, avoidance and escape tasks. +P < .05 
(Duncan’s test) compared with the control group.
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In contrast to the above SPS test, a similar procedure 
known as the Trier Social Stress Test (TSST), in which 
the participant faces an audience and is requested to 
perform arithmetical calculations (Kirchbaum, Pirke, 
& Hellhammer, 1993), has been shown to increase 
salivary cortisol in normal volunteers, but fail to 
do so in PD patients (Petrowski, Herold, Joraschky, 
Wittchen, & Kirschbaum, 2010). These results 
further support the view that PD patients lack cortisol 
responsivity to acute uncontrollable psychosocial 
stress. This unresponsiveness of the HPA axis seems 
to be rather specific, since in the mentioned study a 
normal cortisol awakening response in the morning 
has been recorded in the same patients.
Conclusions
The preceding evidence indicates that anxiety 
and panic are qualitatively different emotional states, 
which are related to the defense reactions to potential 
and proximal threat, respectively. Equally different are 
the related pathologies, GAD and PD, which differ 
both in their symptomatology and in the response 
to pharmacotherapy. Thus, specific neurobiological 
processes underlie each of these conditions. In regard 
Figure 2. Upper panel: Mean salivary cortisol concentration 
before and after the simulated public speaking (SPS) test, 
measured in 18 symptomatic panic patients, 16 nonsymptomatic 
patients and 17 healthy controls. The initial measure was taken 
25 minutes after the subject arrived in the laboratory. The last 
measure is the average of the highest value for each participant 
along 60 minutes starting at end of the speech. Measurements 
were taken immediately, 15, 30 and 60 minutes after the 
speech. Lower panel: Mean VAMS anxiety factor along the 
experimental session in the same subjects. Session phases are: 
B – initial, P – pre-test, A – speech preparation, S – speech 
performance, F – final.
to stress hormones, the analyzed data suggest that while 
anxiety activates both the HPA and the sympatho-
adrenal axes, the panic attack causes major sympathetic 
activation, but has little effect on the HPA axis.
At a more general level, the distinction between 
the hormonal responses to anxiety as compared to 
panic supports the view held by Palkovits that there 
are specific adaptive responses to each types of stress. 
This casts doubts on the existence of a GAS and, 
therefore on Selyes’ original concept of stress itself. 
Even the alternative concept of stress as “a state 
of threatened to homeostasis” (Pacák & Palkovits, 
2001) may be redundant to Cannon’s notion of 
homeostasis, which implies that the organism tends 
to keep its internal state (Claude Bernard’s milieu 
intérieur) within narrow limits through specific 
adaptive responses that tend to correct any provoked 
imbalance. Therefore, in spite of its major impact on 
research (heuristic value), on common knowledge 
and on every day life, the explanatory value of the 
concept of stress needs reevaluation.
Figure 3. Plasma cortisol and prolactin levels along the SPS 
experimental session, measured in 37 healthy male volunteers 
treated with an acute oral doses of 10 mg (n = 14) or 20 
mg (n = 11) of escitalopram, compared to placebo (n = 12). 
Measurements were taken 60 minutes after the arrival in the 
laboratory (B), two hours after drug or placebo intake and 
before the speech (P), as well as immediately (0), and 15, 
30 and 60 minutes after the end of the speech. *Significantly 
different from PT and from other two groups.
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